Skip to content

CTKB

Cytek Biosciences, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$4.66
−0.96%
Ask drillr
Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
P/E (Fwd)
EV/EBITDA
−13.6x
Market Cap
$605.07M
RSI (14)
52.2
1D Return
−0.96%
YTD Return
−7.82%
SummaryUpdated Jun 1, 2026

Cytek Biosciences, Inc. (NASDAQ:CTKB) is a cell analysis solutions company founded in 1992 and headquartered in Fremont, California. Originally known as Cytoville, Inc., the company changed its name to Cytek Biosciences in August 2015 and went public in July 2021. Cytek specializes in developing and manufacturing advanced flow cytometry instruments and related products that enable researchers and clinicians to analyze individual cells with unprecedented precision and detail. The company has established itself as a pioneer in <b>Full Spectrum Profiling (FSP)</b> technology, which represents a significant advancement over conventional flow cytometry methods used in biomedical research and clinical applications.

Similar companies

Latest newsMore news →